Stada expands OTC business with portfolio of GSK drugsGermany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products Share XStada expands OTC business with portfolio of GSK drugshttps://pharmaphorum.com/news/stada-expands-otc-business-with-portfolio-of-gsk-drugs/
Takeda nets $660m from product selloff to Germany’s StadaTakeda has divested another block of products it views as lying outside its main focus, selling various drugs Share XTakeda nets $660m from product selloff to Germany’s Stadahttps://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/
